Zidovudine-β-Lactam Pronucleoside Strategy for Selective Delivery into Gram-Negative Bacteria Triggered by β-Lactamases - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue ACS Infectious Diseases Année : 2023

Zidovudine-β-Lactam Pronucleoside Strategy for Selective Delivery into Gram-Negative Bacteria Triggered by β-Lactamases

Résumé

Addressing antibacterial resistance is a major concern of the modern world. The development of new approaches to meet this deadly threat is a critical priority. In this article, we investigate a new approach to negate bacterial resistance: exploit the βlactam bond cleavage by β-lactamases to selectively trigger antibacterial prodrugs into the bacterial periplasm. Indeed, multidrugresistant Gram-negative pathogens commonly produce several β-lactamases able to inactivate βlactam antibiotics, our most reliable and widely used therapeutic option. The chemical structure of those prodrugs is based on a monobactam promoiety, covalently attached to the active antibacterial substance, the zidovudine (AZT). We describe the synthesis of 10 prodrug analogs (5a-h) in 4-9 steps and their biological activity. Selective enzymatic activation by a panel of β-lactamases is demonstrated and subsequent structure-activity relationships (SARs) are discussed. The best compounds are further evaluated for their activity on both laboratory strains and clinical isolates, preliminary stability, and toxicity.
Fichier principal
Vignette du fichier
Rosales-Hurtado M. revised manuscript.pdf (710.23 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04321173 , version 1 (04-12-2023)

Identifiants

Citer

Miyanou Rosales-Hurtado, Filomena Sannio, Lindita Lari, Federica Verdirosa, Georges Feller, et al.. Zidovudine-β-Lactam Pronucleoside Strategy for Selective Delivery into Gram-Negative Bacteria Triggered by β-Lactamases. ACS Infectious Diseases, 2023, 9 (8), pp.1546-1557. ⟨10.1021/acsinfecdis.3c00110⟩. ⟨hal-04321173⟩
37 Consultations
23 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More